583 related articles for article (PubMed ID: 14999796)
1. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins.
Lapeyre M; Bollet MA; Racadot S; Geoffrois L; Kaminsky MC; Hoffstetter S; Dolivet G; Toussaint B; Luporsi E; Peiffert D
Head Neck; 2004 Mar; 26(3):216-23. PubMed ID: 14999796
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
[TBL] [Abstract][Full Text] [Related]
3. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
4. [Interstitial and percutaneous radiotherapy after limited surgery in carcinoma of the oral cavity].
Fietkau R; Grabenbauer GG; Iro H; Müller RG; Farmand M; Atendorf-Hofmann A; Sauer R
Strahlenther Onkol; 1991 Oct; 167(10):591-8. PubMed ID: 1948644
[TBL] [Abstract][Full Text] [Related]
5. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
[TBL] [Abstract][Full Text] [Related]
7. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
8. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
9. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment.
Lin CS; Jen YM; Cheng MF; Lin YS; Su WF; Hwang JM; Chang LP; Chao HL; Liu DW; Lin HY; Shum WY
Head Neck; 2006 Feb; 28(2):150-7. PubMed ID: 16200628
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy and curietherapy of squamous cell carcinoma of the posterior pharyngeal wall (excluding the nasopharynx)].
Chenal C; Julienne V; Fleury F; Desprez P
Bull Cancer Radiother; 1996; 83(1):54-9. PubMed ID: 8679282
[TBL] [Abstract][Full Text] [Related]
12. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
[TBL] [Abstract][Full Text] [Related]
13. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors and survival rates in oral cavity cancers].
Uğurluer G; Ozyurt SC; Aksaray F; Aslan N; Habiboğlu R; Tümöz M
Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):64-71. PubMed ID: 16763419
[TBL] [Abstract][Full Text] [Related]
15. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
16. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer.
Do L; Puthawala A; Syed N
Brachytherapy; 2009; 8(4):385-91. PubMed ID: 19733128
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
18. The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity.
Shrime MG; Gullane PJ; Dawson L; Kim J; Gilbert RW; Irish JC; Brown DH; Goldstein DP
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):225-8. PubMed ID: 20231637
[TBL] [Abstract][Full Text] [Related]
19. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue.
van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR
Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539
[TBL] [Abstract][Full Text] [Related]
20. Perioperative interstitial brachytherapy for soft tissue sarcomas: prognostic factors and long-term results of 155 patients.
Laskar S; Bahl G; Puri A; Agarwal MG; Muckaden M; Patil N; Jambhekar N; Gupta S; Deshpande DD; Shrivastava SK; Dinshaw KA
Ann Surg Oncol; 2007 Feb; 14(2):560-7. PubMed ID: 17115103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
